Well if both demonstrate efficacy I would believe around 7-8$ would be conservative target. That would only be a 700-800 million market cap. If we see a NASDAQ uplist and some institutional interest could be $10+ in my opinion.
Calimmune, page-8
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)